🔎 Trials Near Me

Home › NCT02168088

Molecular Autopsy Study

RecruitingObservational study

Molecular Autopsy for Sudden Cardiovascular Death

Who can join

Up to age 45 · All sexes

Full eligibility criteria
Inclusion Criteria:

* Index case age between birth - 45 years
* Clinical presentation of sudden / unexplained death (believed to be cardiac in nature OR secondary to a massive unprovoked pulmonary embolism with no prior diagnosis of prothrombotic disease)

Exclusion Criteria:

* Premature death secondary to murder, suicide or external causal event
* Premature death thought secondary to known chronic comorbid medical condition
* Premature death thought secondary to end-organ failure (kidney, liver, lung) other than heart
* Previously diagnosed with hypertrophic cardiomyopathy (HCM)
* Prior myocardial infarction (regardless of stenting or bypass)
* Prior cerebrovascular accident (stroke or TIA)
* History of open heart surgery (for any reason)
* History of severe, untreated hypertensive heart disease
* History of illicit drug use
* History of heavy alcohol abuse
* History of severe pulmonary disease
* History of morbid obesity

About the study

This study seeks to incorporate genetic testing into the postmortem examination of cases of sudden unexplained death.

Sponsor: Scripps Translational Science Institute · Participants: 100 · Started: 2014-06

Contact the study team

Official record on ClinicalTrials.gov — NCT02168088

Locations in the U.S.

CaliforniaScripps Translational Science Institute, La Jolla

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.